GLP-1 Market
LLY $1409.38 ▼ -0.1% NVO $40.19 ▼ -0.6% PFE $30.00 ▼ -2.2% VKTX $26.09 ▼ -2.8% KLRA $12.58 ▲ +3.5% GPCR $20.35 ▼ -0.6% RHHBY $59.18 ▼ -2.5%
Market data delayed up to 20 min · Source: Twelve Data

Empowering you to have better conversations with your doctor.

Subscribe
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Liposomal Iron

Company
Medeni Şermet
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
None currently listed

Efficacy results: Not yet reported

No recruiting studies currently listed

See all studies for this drug

Data source: ClinicalTrials.gov · trial data as of Nov 4, 2026

Trial details
  • Completed NCT NCT01864161

    Endovenous Versus Liposomal Iron in CKD

    Not yet reported Federico II University 100 participants Est. completion 2013-05 1 site Stand-alone
    Chronic kidney disease Other conditions: Iron Deficiency Anemia
    View official trial listing →
  • Status unknown NCT NCT02760940

    Anemia in Inflammatory Bowel Disease

    Not yet reported Federal University of Juiz de Fora 200 participants Est. completion 2018-08 Stand-alone
    Other conditions: Anemia, Bowel Diseases, Inflammatory
    View official trial listing →
  • Completed NCT NCT03112187

    FLIPS: Ferfer Liposomal Iron Performance Study

    Not yet reported PharmEvo Pvt Ltd 400 participants Est. completion 2019-01-31 1 site
    Other conditions: Iron Deficiency Anemia
    View official trial listing →
  • Status unknown NCT NCT05714176

    Comparative Study Between Oral Liposomal Iron,Iron Supported Lactoferrin and IV Iron Dextran in CKD Children

    Not yet reported Menoufia University 90 participants Est. completion 2024-12-31 Stand-alone
    Chronic kidney disease
    View official trial listing →
  • Status unknown NCT NCT05957328

    A Study to Compare Liposomal Iron With Ferrous Ascorbate in the Treatment of Iron Deficiency Anemia in Children

    Not yet reported All India Institute of Medical Sciences 96 participants Est. completion 2025-02 1 site
    Other conditions: Nutritional Anemia
    View official trial listing →
  • Completed NCT NCT06556134

    Oral Liposomal Iron Versus Injectable Iron Sucrose for Anemia Treatment in Non-Dialysis Chronic Kidney Disease Patients

    Not yet reported Centre Hospitalier Hassan II - Fès 27 participants Est. completion 2024-01-10 1 site
    Chronic kidney disease
    View official trial listing →
  • Status unknown NCT NCT06669052

    Liposomal Iron 30 mg Supplement in Non-anemic Pregnant Females

    Orchidia pharmaceutical Industries 714 participants Est. completion 2025-05
    Other conditions: Anemia of Pregnancy, Iron Deficiency Anemia
    View official trial listing →
  • Completed NCT NCT07366502

    Liposomal vs Conventional Oral Iron After Sleeve Gastrectomy

    Not yet reported Medeni Şermet 70 participants Est. completion 2026-07-31 1 site Stand-alone
    Other conditions: İron Deficiency Anemia, Liposomal Iron Replacement, Conventional Iron Replacement
    View official trial listing →
  • Active, not recruiting NCT NCT07483645

    Effectiveness and Acceptability of LISEFEX® (Liposomal Iron With Vitamin C and Fiber) in People With Iron Deficiency Anemia.

    Carnot Laboratories 74 participants Est. completion 2026-03-30 1 site
    Other conditions: Iron Deficiency Anemia
    View official trial listing →
  • Not yet recruiting NCT NCT07556731

    Comparison of Ferrous Salt vs. Liposomal Iron in Adult Women With Iron-Deficiency Anemia

    Not yet reported Hospital General de Mexico 100 participants Est. completion 2027-07-01 1 site
    Other conditions: Iron-deficiency Anemia (IDA), Hemoglobin, Iron Deficiencies, Adverse Effect
    View official trial listing →
  • Enrolling by invitation NCT NCT07667205

    Liposomal Iron Versus Ferrous Iron Supplementation for Early Prophylaxis of Iron Deficiency Anemia in Preterm Neonates

    Not yet reported Ain Shams University 60 participants Est. completion 2026-12-25 1 site
    Other conditions: Iron Deficiency Anemia in Preterm Neaonates
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources

Also known as: Liposomal Iron, nano encapsule bioferrP

Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.